Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms P16A |
Target |
Action degraders |
Mechanism HMGCR degraders(HMG-CoA reductase degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC57H63FN8O12 |
InChIKeyPAYQRGVUYUNIDJ-RFIMGWBHSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | China | 22 Apr 2020 |